Sponsor:
Cerenovus, Part of DePuy Synthes Products, Inc.
Code:
NCT06735833
Conditions
Migraine Disorders
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Middle Meningeal Artery embolization
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-24. This information was provided to ClinicalTrials.gov by Cerenovus, Part of DePuy Synthes Products, Inc. on 2026-07-06.